FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer

Document Details

Document Type
Pub Defense Publication
Publication Date
Nov 01, 2018
Source ID
10.1016/j.canlet.2018.08.015

Entities

People

  • Ashwini A. Katre
  • Charles N. Landen
  • Karina J. Yoon
  • Kelly M. Kreitzburg
  • Patsy G. Oliver
  • Rebecca B. Vance
  • Rebecca C Arend
  • Robert C.a.m. Van Waardenburg
  • Ronald D. Alvarez
  • Samuel C. Fehling
  • Tracy L. Gamblin

Organizations

  • Comprehensive Cancer Center, University of Alabama at Birmingham